Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to take the high risk of losing your money.

Cassava Sciences Inc
(NASDAQ:SAVA) share price

Add to watchlist
0
0pts
0%
1D
3D
1W
1M
3M
1Y
Interval 30 min

Pricing is indicative. Past performance is not a reliable indicator of future results.

Discover our trading platforms
1 Hour
-
Day
-
7 Day
-
30 Day
-
CLIENT SENTIMENT
83% long

About Cassava Sciences Inc

Cassava Sciences is a US clinical-stage biopharmaceutical company with a focus on neuroscience. It was founded in 1998 with headquarters in Austin, Texas. The business develops medicines for patients with debilitating neurodegenerative conditions, such as Alzheimer’s, Huntington’s, and Parkinson’s disease. Cassava’s main products include Simufilam, an investigative oral drug that aims to stabilise critical proteins in the brain, and SavaDx, a blood-based diagnostic used to detect Alzheimer’s disease. It has previously worked drugs aimed to treat irritable bowel syndrome (IBS). Cassava Sciences stock is listed on the Nasdaq exchange in New York. Start spread betting or trading CFDs on our Cassava Sciences share price.

Why 1 million+ global traders and investors* choose CMC1

  • Access to 12,000 financial instruments

  • Lightning-fast execution2

  • 99.95%+ platform stability**

  • 99.9% fill rate with 0.0029s execution*

  • Tax-free profits on spread bets; no stamp duty on CFDs4

Trading details

minimum spread
N/A
minimum size (new)
0.001
Shorting allowed
Yes
GSLO allowed
No

Holding costs

Daily - Sell
0.00
Daily - Buy
0.00
Yearly - Sell
0.00
Yearly - Buy
0.00

Margin rates

Tier Units Rates

Trading hours

(shown in London local time )

Related instruments